Cargando…
On the development of B-Raf inhibitors acting through innovative mechanisms
B-Raf is a protein kinase participating to the regulation of many biological processes in cells. Several studies have demonstrated that this protein is frequently upregulated in human cancers, especially when it bears activating mutations. In the last years, few ATP-competitive inhibitors of B-Raf h...
Autor principal: | Pinzi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043679/ https://www.ncbi.nlm.nih.gov/pubmed/35529278 http://dx.doi.org/10.12688/f1000research.108761.2 |
Ejemplares similares
-
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
por: Pinzi, Luca, et al.
Publicado: (2021) -
Mechanisms of resistance to RAF inhibitors in melanoma
por: Aplin, Andrew E., et al.
Publicado: (2011) -
Technology innovation for infectious diseases in the developing world
por: So, Anthony D, et al.
Publicado: (2012) -
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017) -
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
por: Scaini, Maria Chiara, et al.
Publicado: (2023)